Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Yang, Kai-Chun
Liao, Yin-To
Yang, Yen-Kuang
Lin, Shih-Ku
Liang, Chih-Sung
and
Bai, Ya-Mei
2021.
Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN).
CNS Drugs,
Vol. 35,
Issue. 8,
p.
893.
Perlstein, Itay
Merenlender Wagner, Avia
Gomeni, Roberto
Lamson, Michael
Harary, Eran
Spiegelstein, Ofer
Kalmanczhelyi, Attila
Tiver, Ryan
Loupe, Pippa
Levi, Micha
and
Elgart, Anna
2022.
Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone.
Clinical Pharmacology in Drug Development,
Vol. 11,
Issue. 7,
p.
865.
Tan, Eric J.
Rossell, Susan L.
Subotnik, Kenneth L.
Ventura, Joseph
and
Nuechterlein, Keith H.
2022.
Cognitive heterogeneity in first-episode psychosis and its relationship with premorbid developmental adjustment.
Psychological Medicine,
Vol. 52,
Issue. 16,
p.
3885.
Nuechterlein, Keith H.
Green, Michael F.
and
Kern, Robert S.
2022.
Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework.
Vol. 63,
Issue. ,
p.
1.
Trapp, Wolfgang
Heid, Andreas
Röder, Susanne
Wimmer, Franziska
and
Hajak, Göran
2022.
Cognitive Remediation in Psychiatric Disorders: State of the Evidence, Future Perspectives, and Some Bold Ideas.
Brain Sciences,
Vol. 12,
Issue. 6,
p.
683.
Harvey, Philip D.
Depp, Colin A.
Rizzo, Albert A.
Strauss, Gregory P.
Spelber, David
Carpenter, Linda L.
Kalin, Ned H.
Krystal, John H.
McDonald, William M.
Nemeroff, Charles B.
Rodriguez, Carolyn I.
Widge, Alik S.
and
Torous, John
2022.
Technology and Mental Health: State of the Art for Assessment and Treatment.
American Journal of Psychiatry,
Vol. 179,
Issue. 12,
p.
897.
Nuechterlein, Keith H.
McEwen, Sarah C.
Ventura, Joseph
Subotnik, Kenneth L.
Turner, Luana R.
Boucher, Michael
Casaus, Laurie R.
Distler, Margaret G.
and
Hayata, Jacqueline N.
2023.
Aerobic exercise enhances cognitive training effects in first-episode schizophrenia: randomized clinical trial demonstrates cognitive and functional gains.
Psychological Medicine,
Vol. 53,
Issue. 10,
p.
4751.
Wykes, Til
Stringer, Dominic
Boadu, Janette
Tinch-Taylor, Rose
Csipke, Emese
Cella, Matteo
Pickles, Andrew
McCrone, Paul
Reeder, Clare
Birchwood, Max
Fowler, David
Greenwood, Kathryn
Johnson, Sonia
Perez, Jesus
Ritunnano, Rosa
Thompson, Andrew
Upthegrove, Rachel
Wilson, Jon
Kenny, Alex
Isok, Iris
and
Joyce, Eileen M
2023.
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants.
Schizophrenia Bulletin,
Vol. 49,
Issue. 3,
p.
614.
Gu, Hao
Dai, Guoxin
Teng, Zhongqiu
Geng, Lina
and
Xu, Wei
2023.
A liquid chromatography-miniature mass spectrometry (LC-Mini MS) method for quantitative analysis of risperidone and 9-hydroxyrisperidone in plasma.
The Analyst,
Vol. 148,
Issue. 15,
p.
3518.
Kuo, Susan S.
Ventura, Joseph
Forsyth, Jennifer K.
Subotnik, Kenneth L.
Turner, Luana R.
and
Nuechterlein, Keith H.
2023.
Developmental trajectories of premorbid functioning predict cognitive remediation treatment response in first-episode schizophrenia.
Psychological Medicine,
Vol. 53,
Issue. 13,
p.
6132.
Zhang, Kai
Miao, Shipan
Yao, Yitan
Yang, Yating
Shi, Shengya
Luo, Bei
Li, Mengdie
Zhang, Ling
and
Liu, Huanzhong
2023.
Efficacy and safety of prophylactic use of benzhexol after risperidone treatment.
Heliyon,
Vol. 9,
Issue. 3,
p.
e14199.
Ventura, Joseph
Subotnik, Kenneth L.
Han, Sam
Hellemann, Gerhard S.
Green, Michael F.
and
Nuechterlein, Keith H.
2023.
The relationship between sex and functional outcome in first-episode schizophrenia: the role of premorbid adjustment and insight.
Psychological Medicine,
Vol. 53,
Issue. 14,
p.
6878.
Petkari, Eleni
Martín-María, Natalia
Sánchez-Gutiérrez, Teresa
Fernández-Castilla, Belén
and
Calvo, Ana
2023.
A meta-analysis of cognitive interventions for patients with recent onset psychosis: are they effective for improving functioning?.
Psychological Medicine,
Vol. 53,
Issue. 8,
p.
3306.
Vita, Antonio
Barlati, Stefano
Ceraso, Anna
Deste, Giacomo
Nibbio, Gabriele
and
Wykes, Til
2023.
Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Psychological Medicine,
Vol. 53,
Issue. 8,
p.
3661.
Chen, Wei
Wu, Chi-Shin
Liu, Chen-Chung
Kuo, Po-Hsiu
Chan, Hung-Yu
Lin, Yi-Hsuan
Chung, Yu-Chu Ella
and
Chen, Wei J.
2024.
In-Hospital Use of Long-Acting Injectable Antipsychotics and Readmission Risk in Patients With First-Admission Schizophrenia in Taiwan.
JAMA Network Open,
Vol. 7,
Issue. 6,
p.
e2417006.
Le, Thanh P.
Ventura, Joseph
Subotnik, Kenneth L.
and
Nuechterlein, Keith H.
2024.
Intrinsic motivation predicts cognitive and functional gains during coordinated specialty care for first-episode schizophrenia.
Schizophrenia Research,
Vol. 266,
Issue. ,
p.
249.
Avila, Alessia
and
Novais, Filipa
2024.
Systematic Review of Computerised Cognitive Remediation interventions in Early Psychosis: Do we Still Need “Somebody with a Human Touch”?.
Current Treatment Options in Psychiatry,
Vol. 11,
Issue. 3,
p.
227.
Li, Juanhua
Xu, Yuanguang
Wang, Xin
Liu, Caixing
Li, Zezhi
Xiu, Meihong
and
Chen, Hongying
2024.
Cognitive improvements linked to lysophosphatidylethanolamine after olanzapine treatment in drug-naïve first-episode schizophrenia.
Metabolomics,
Vol. 20,
Issue. 5,
Filip, Tess F.
Hellemann, Gerhard S.
Ventura, Joseph
Subotnik, Kenneth L.
Green, Michael F.
Nuechterlein, Keith H.
and
McCleery, Amanda
2024.
Defeatist performance beliefs in individuals with recent-onset schizophrenia: Relationships with cognition and negative symptoms.
Schizophrenia Research,
Vol. 270,
Issue. ,
p.
212.
Cai, Chao
Kozma, Chris
Patel, Charmi
Benson, Carmela
Yunusa, Ismaeel
Zhao, Pujing
Reeder, Gene
Narasimhan, Meera
and
Bank, Robert L.
2024.
Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia.
Journal of Managed Care & Specialty Pharmacy,
Vol. 30,
Issue. 6,
p.
549.